Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kolmar Korea Eyes Pharma Expansion Via CJ HealthCare Acquisition

Executive Summary

The acquisition of mid-size South Korean pharma firm CJ HealthCare is set to boost Kolmar Korea's pharma business, enabling the cosmetics and pharma company to transform into a larger and more integrated healthcare firm.

Advertisement

Related Content

Biotech Deals Stand Out In 2018 Korean Licensing Trends
Korea 2018 Review: Hopes And Worries Coexist In Pharma Sector
Biopharma Quarterly Dealmaking Statistics, Q1 2018
Deal Watch: Fresenius Buyout Of Akorn Potentially Threatened By Data Integrity Issues
Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine
M&A Buzz In Korea: CJ HealthCare On the Block

Topics

Advertisement
UsernamePublicRestriction

Register

SC100437

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel